Crohn's & Colitis Meeting to Transform Inflammatory bowel disease (IBD)
In-Person Event
Jan 18 - 20, 2018
Las Vegas, Nevada, USAOVERVIEW
Crohn's & Colitis Meeting to Transform Inflammatory bowel disease (IBD) is organized by American Gastroenterological Association (AGA), Crohn's & Colitis Foundation and will be held during Jan 18 - 20, 2018 at Aria Resort and Casino, Las Vegas, Nevada, United States of America. This CME Conference has been approved for a maximum of 11.5 AMA PRA Category 1 Credits.
The Crohn's & Colitis Foundation and AGA are partnering on a new annual conference for health-care professionals and researchers. By joining the nation's leading IBD patient organization with the premier gastroenterological professional organization, this will be the must-attend IBD conference, bringing state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.
This Congress is the must-attend meeting for all IBD professionals, offering a bold, multidisciplinary, forward-thinking approach to learning in the IBD space. Health-care professionals and research investigators across all disciplines will engage in the mission to transform IBD care and advance research by learning together as one care team.
Sessions will focus on multidisciplinary clinical, surgical and research approaches to the current realities and challenges in the disease space and will incorporate the latest basic, translational and clinical research to address clinical questions. Faculty includes leading GIs, surgeons, pediatricians, nurse practitioners and physician assistants, IBD nurses, dietitians, mental health professionals, radiologists and pathologists.
Sessions will emphasize case studies with multi-disciplinary panel discussions covering:
• Management of Complicated IBD
• Defining Optimal Treatment Algorithms
• Clinical and Research Challenges
Learning Objectives :
• Describe the multi-faceted challenges in IBD research and clinical approaches.
• Identify the strengths and limitations of treatment algorithms.
• Recognize the value of multi-disciplinary dialogue in IBD management through case presentations.
• Discuss the importance of mucosal healing in IBD management.
• Summarize microbiota-based therapies currently in development, including their proposed indications and mechanisms of action.
• Report the epidemiology of IBD and the role of the environment, genetics, immune system and microbiome.
• Define indications for and interpretation of diagnostic testing in IBD.
Additional details will be posted as soon as they are available.
The Crohn's & Colitis Foundation and AGA are partnering on a new annual conference for health-care professionals and researchers. By joining the nation's leading IBD patient organization with the premier gastroenterological professional organization, this will be the must-attend IBD conference, bringing state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.
This Congress is the must-attend meeting for all IBD professionals, offering a bold, multidisciplinary, forward-thinking approach to learning in the IBD space. Health-care professionals and research investigators across all disciplines will engage in the mission to transform IBD care and advance research by learning together as one care team.
Sessions will focus on multidisciplinary clinical, surgical and research approaches to the current realities and challenges in the disease space and will incorporate the latest basic, translational and clinical research to address clinical questions. Faculty includes leading GIs, surgeons, pediatricians, nurse practitioners and physician assistants, IBD nurses, dietitians, mental health professionals, radiologists and pathologists.
Sessions will emphasize case studies with multi-disciplinary panel discussions covering:
• Management of Complicated IBD
• Defining Optimal Treatment Algorithms
• Clinical and Research Challenges
Learning Objectives :
• Describe the multi-faceted challenges in IBD research and clinical approaches.
• Identify the strengths and limitations of treatment algorithms.
• Recognize the value of multi-disciplinary dialogue in IBD management through case presentations.
• Discuss the importance of mucosal healing in IBD management.
• Summarize microbiota-based therapies currently in development, including their proposed indications and mechanisms of action.
• Report the epidemiology of IBD and the role of the environment, genetics, immune system and microbiome.
• Define indications for and interpretation of diagnostic testing in IBD.
Additional details will be posted as soon as they are available.
KEY DATES
18 Jan, 2018
Event Start Date
20 Jan, 2018
Event End Date
SPECIALITIES
GastroenterologySUGGESTED HOTELS
CONFERENCE VENUE
Aria Resort and CasinoRELATED CONFERENCES & LIVE WEBINARS
Quick Links